You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

JAK inhibitor

Showing 51 - 75 of 7,638
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alopecia Areata Trial in New Haven (Tattoo machine (SOL Nova Device))

Completed
  • Alopecia Areata
  • Tattoo machine (SOL Nova Device)
  • New Haven, Connecticut
    Yale University
Dec 7, 2022

Myelofibrosis Trial in Worldwide (Imetelstat, Best Available Therapy (BAT))

Recruiting
  • Myelofibrosis
  • La Jolla, California
  • +165 more
Aug 19, 2022

Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission, Minimal Residual

Terminated
  • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 1, 2020

Estrogen-receptor Positive Invasive Metastatic Breast Cancer Trial in Philadelphia (Ruxolitinib, Exemestane)

Completed
  • Estrogen-receptor Positive Invasive Metastatic Breast Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 29, 2020

Myelofibrosis Trial in Hong Kong (Bomedemstat)

Recruiting
  • Myelofibrosis
  • Hong Kong, Hong Kong
    Department of Medicine, the University of Hong Kong, Queen Mary
Oct 3, 2022

Ustekinumab and Tofacitinib as Third Line Therapy inMulticenter

Completed
  • Ulcerative Colitis
  • Milano, Italy
    Mariangela Allocca
Feb 13, 2023

Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Post-Essential Thrombocythemia MF (Post-ET-MF) Trial in

Recruiting
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Birmingham, Alabama
  • +155 more
Aug 12, 2022

COVID-19 Trial in Russian Federation, United States (Placebo, Ruxolitinib)

Terminated
Has Results
  • COVID-19
  • Scottsdale, Arizona
  • +35 more
Jan 14, 2022

Synovial and Adipose Tissue Composition in Overweight/Obese

Active, not recruiting
  • Rheumatoid Arthritis
  • Assessment of synovial- and adipose tissue-derived inflammatory biomarkers
  • Rome, Italy
    Division of Rheumatology
Mar 2, 2023

JAK Inhibitors in Systemic Sclerosis-associated Interstitial

Recruiting
  • Systemic Sclerosis
  • Interstitial Lung Disease
    • Vandœuvre-lès-Nancy, Grand Est, France
      CHU Nancy
    Jan 19, 2022

    Food Allergy Trial in New York (Abrocitinib)

    Recruiting
    • Food Allergy
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Jul 29, 2022

    Rheumatoid Arthritis Trial in Paris (Baricitinib Oral Tablet [Olumiant], Placebo)

    Recruiting
    • Rheumatoid Arthritis
    • Baricitinib Oral Tablet [Olumiant]
    • Placebo
    • Paris, France
      CHU Pitié Salpêtrière
    Aug 22, 2022

    Solid Tumors, Advanced Malignancies, Metastatic Cancer Trial in United States (INCB052793, gemcitabine, nab-paclitaxel)

    Terminated
    Has Results
    • Solid Tumors
    • +2 more
    • Birmingham, Alabama
    • +13 more
    Apr 6, 2020

    A Prospective, Non-interventional Study of JAKAVI® Treatment in

    Active, not recruiting
    • Polycythemia Vera
    • Jakavi
    • Reutlingen, Baden Wuerttemberg, Germany
    • +98 more
    May 16, 2023

    Myelofibrosis Trial in Worldwide (Selinexor, Physician's Choice Treatment)

    Recruiting
    • Myelofibrosis
    • Los Angeles, California
    • +41 more
    Jan 30, 2023

    Kohlmeier Degos Disease With Neurologic Involvement Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

    Recruiting
    • Kohlmeier Degos Disease With Neurologic Involvement
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 23, 2023

    Lupus Nephritis Trial in Assiut (Anti JAK1,2)

    Active, not recruiting
    • Lupus Nephritis
    • Anti JAK1,2
    • Assiut, Assuit, Egypt
      Manal Hassanien
    Jun 21, 2022

    Rheumatoid Arthritis Trial in London (Etanercept, tofacitinib)

    Recruiting
    • Rheumatoid Arthritis
    • London, Ontario, Canada
      Rheumatology Clinic, St. Joseph's Health Care
    May 10, 2022

    Alopecia Areata Trial in Bangkok (Tofacitinib)

    Completed
    Has Results
    • Alopecia Areata
    • Bangkok, Thailand
      Institute of Dermatology
    Mar 28, 2022

    Myeloproliferative Diseases Trial in Bergamo, Pavia (ITF2357)

    Completed
    Has Results
    • Myeloproliferative Diseases
    • Bergamo, Italy
    • +1 more
    Dec 2, 2019

    Janus Kinase Inhibitors Vs Tumor Necrosis Factor Inhibitors in

    Not yet recruiting
    • Rheumatoid Arthritis
    • Observation
    • (no location specified)
    Oct 8, 2022

    Leukemia Trial in Canada, Puerto Rico, United States (Ruxolitinib, Asparaginase Erwinia Chrysanthemi, Cyclophosphamide)

    Recruiting
    • Leukemia
    • Birmingham, Alabama
    • +109 more
    Aug 11, 2022

    Colorectal Cancer (CRC), Endometrial Cancer, Melanoma Trial in United States (Pembrolizumab, itacitinib, INCB050465)

    Completed
    • Colorectal Cancer (CRC)
    • +10 more
    • San Francisco, California
    • +16 more
    Mar 30, 2022

    Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)

    Active, not recruiting
    • Myelofibrosis
    • Polycythemia Vera
    • Phoenix, Arizona
    • +4 more
    Jun 20, 2022

    Phase 1 Trial in Brussels (PF-04965842, Midazolam)

    Completed
    • Phase 1
    • Brussels, Belgium
      Pfizer Clinical Research Unit
    Mar 19, 2020